RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Sellas Life Sciences Group Net Income 2024

Sellas Life Sciences Group Net Income

-40.83 M USD

Sellas Life Sciences Group Dividend yield

Ticker

SLS

ISIN

US81642T2096

WKN

A2PU3T

In 2024, Sellas Life Sciences Group's profit amounted to -40.83 M USD, a 9.34% increase from the -37.34 M USD profit recorded in the previous year.

The Sellas Life Sciences Group Net Income history

YEARNET INCOME (undefined USD)
2029e202.4
2028e111.99
2027e28.87
2026e-18.96
2025e-31.21
2024e-40.83
2023-37.34
2022-41.3
2021-20.7
2020-16.84
2019-27.95
2018-41.25
2017-24.43
2016-17.68
2015-63.9
2014-36.61
2013-76.68
2012-34.97
2011-11.49
2010-11.99
2009-18.39
2008-14.37
2007-10.99
2006-2.41
2005-2.21
2004-3.27

Sellas Life Sciences Group Aktienanalyse

What does Sellas Life Sciences Group do?

Sellas Life Sciences Group Inc is a biopharmaceutical company specializing in the development and marketing of products for the treatment of cancer. It was founded in 2012 and is headquartered in New York City. The company's history began with the discovery of a groundbreaking drug called "Galiximab," which can be used to treat lymph node cancer. In recent years, Sellas Life Sciences Group Inc has also advanced the development of immunotherapy products that harness the body's immune system to fight malignant cancer cells. The company's business model is focused on developing pharmaceutical products and providing clinical services. It has various divisions dedicated to the development of cancer therapies, including research and development partnerships with leading institutions such as the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute, and the Dana-Farber Cancer Institute. Sellas aims to improve the lives of cancer patients through the development of advanced therapies. Sellas Life Sciences Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Sellas Life Sciences Group's Profit Margins

The profit margins of Sellas Life Sciences Group represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Sellas Life Sciences Group's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Sellas Life Sciences Group's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Sellas Life Sciences Group's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Sellas Life Sciences Group’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Sellas Life Sciences Group Stock

How much profit has Sellas Life Sciences Group made this year?

Sellas Life Sciences Group has made -40.83 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 9.34% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Sellas Life Sciences Group publish its earnings?

Sellas Life Sciences Group publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Sellas Life Sciences Group?

The profits of Sellas Life Sciences Group are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Sellas Life Sciences Group?

You can learn more about the earnings of Sellas Life Sciences Group by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Sellas Life Sciences Group pay?

Over the past 12 months, Sellas Life Sciences Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sellas Life Sciences Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Sellas Life Sciences Group?

The current dividend yield of Sellas Life Sciences Group is .

When does Sellas Life Sciences Group pay dividends?

Sellas Life Sciences Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sellas Life Sciences Group?

Sellas Life Sciences Group paid dividends every year for the past 0 years.

What is the dividend of Sellas Life Sciences Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sellas Life Sciences Group located?

Sellas Life Sciences Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sellas Life Sciences Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sellas Life Sciences Group from 5/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/27/2024.

When did Sellas Life Sciences Group pay the last dividend?

The last dividend was paid out on 5/27/2024.

What was the dividend of Sellas Life Sciences Group in the year 2023?

In the year 2023, Sellas Life Sciences Group distributed 0 USD as dividends.

In which currency does Sellas Life Sciences Group pay out the dividend?

The dividends of Sellas Life Sciences Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sellas Life Sciences Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sellas Life Sciences Group

Our stock analysis for Sellas Life Sciences Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sellas Life Sciences Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.